Resources

White Paper: Contractors vs FTEs in BioPharmaceutical Drug Development.

Benefits and Challenges of Adopting a Hybrid Resource Model by Michael O’Brien NGT BioPharma Consultants CEO. An in-depth discussion on emerging Pharma models & flexible workforces from lab to mid-level management roles.